Quick Answer
Bioquest Corp reported Cash and Equivalents of $33.5 thousand for fiscal year 2022.
Bioquest Corp Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2022 | $33.5K | +12800.0% |
| 2021 | $260.00 | +56.6% |
| 2020 | $166.00 | -100.0% |
| 2014 | $543.9K | +6716.9% |
| 2013 | $8.0K | +743.3% |
| 2012 | $946.00 | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| July 31, 2022 | $15.0K | +446.6% | -55.4% |
| April 30, 2022 | $33.5K | +12800.0% | +28813.8% |
| January 31, 2022 | $116.00 | +93.3% | -85.8% |
| October 31, 2021 | $818.00 | +1068.6% | -70.1% |
| July 31, 2021 | $2.7K | — | +952.3% |
| April 30, 2021 | $260.00 | +56.6% | +333.3% |
| January 31, 2021 | $60.00 | — | -14.3% |
| October 31, 2020 | $70.00 | — | -57.8% |
- Bioquest Corp showed an increase of +12800.0% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2012–2022 period, Bioquest Corp’s cash and equivalents has grown by 3445.5% (from $946.00 to $33.5 thousand).
- The most recent figure is from Bioquest Corp’s fiscal year 2022 report (Form 10-K), filed with the SEC on August 15, 2022.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: